MediPal Holdings Corporation
MediPal Holdings Corporation Fundamental Analysis
MediPal Holdings Corporation (MAHLY) shows moderate financial fundamentals with a PE ratio of 13.74, profit margin of 1.10%, and ROE of 6.71%. The company generates $3801.3B in annual revenue with moderate year-over-year growth of 3.16%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 36.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MAHLY's fundamental strength across five key dimensions:
Efficiency Score
WeakMAHLY struggles to generate sufficient returns from assets.
Valuation Score
ExcellentMAHLY trades at attractive valuation levels.
Growth Score
WeakMAHLY faces weak or negative growth trends.
Financial Health Score
ExcellentMAHLY maintains a strong and stable balance sheet.
Profitability Score
WeakMAHLY struggles to sustain strong margins.
Key Financial Metrics
Is MAHLY Expensive or Cheap?
P/E Ratio
MAHLY trades at 13.74 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, MAHLY's PEG of 0.03 indicates potential undervaluation.
Price to Book
The market values MediPal Holdings Corporation at 0.90 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.91 times EBITDA. This is generally considered low.
How Well Does MAHLY Make Money?
Net Profit Margin
For every $100 in sales, MediPal Holdings Corporation keeps $1.10 as profit after all expenses.
Operating Margin
Core operations generate 1.42 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $6.71 in profit for every $100 of shareholder equity.
ROA
MediPal Holdings Corporation generates $2.08 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
MediPal Holdings Corporation generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
MediPal Holdings Corporation generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
MAHLY converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
13.74
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.03
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.90
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.15
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.07
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.25
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.07
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.06
vs 25 benchmark
How MAHLY Stacks Against Its Sector Peers
| Metric | MAHLY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 13.74 | 28.31 | Better (Cheaper) |
| ROE | 6.71% | 699.00% | Weak |
| Net Margin | 1.10% | -130884.00% (disorted) | Weak |
| Debt/Equity | 0.07 | 0.34 | Strong (Low Leverage) |
| Current Ratio | 1.25 | 2775.16 | Neutral |
| ROA | 2.08% | -14469.00% (disorted) | Weak |
MAHLY outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews MediPal Holdings Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
16.91%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
9.90%
Industry Style: Defensive, Growth, Innovation
GrowingFCF CAGR
10.22%
Industry Style: Defensive, Growth, Innovation
High Growth